A carregar...
Statin Pharmacogenomics: Opportunities to Improve Patient Outcomes and Healthcare Costs with Genetic Testing
HMG-CoA reductase inhibitors, commonly known as statins, are some of the most widely prescribed medications worldwide and have been shown to be effective at lowering cholesterol in numerous long-term prospective trials, yet there are significant limitations to their use. First, patients receiving st...
Na minha lista:
| Publicado no: | J Pers Med |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4251374/ https://ncbi.nlm.nih.gov/pubmed/25562358 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm2040158 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|